EFPIA Supports Uniform Approach By EU Member States On Remote Batch Certification
Requirement For MIA Holders To Demonstrate Time Spent By QPs On Site Raises Concern
Executive Summary
The European federation of research-based drug companies has made suggestions to ensure the consistent adoption of an EU proposal that seeks to continue the flexibilities that were introduced in response to COVID-19-related travel restrictions.